Table 2

Baseline gastric histological grading of the randomised patients

Histological grading (updated Sydney classification)Eradication (Group HpE) (n = 53)Placebo (Group Hp+) (n = 51)p Value
Antral gastritis (%)
    0–25 (9.6)11 (22)
    3–432 (61.5)24 (48)0.19
    5–615 (28.8)15 (30)
Corpus gastritis (%)
    0–225 (49)22 (44.9)
    3–419 (37.3)17 (34.7)0.67
    5–67 (13.7)10 (20.4)
Antral atrophy (%)
    046 (88.5)40 (80)
    14 (7.7)7 (14)0.53
    22 (3.8)2 (4)
    30 (0)1 (2)
Corpus atrophy (%)
    050 (98)47 (95.9)
    11 (2)2 (4.1)0.49
    20 (0)0 (0)
    30 (0)0 (0)
Antral intestinal metaplasia (%)
    038 (73.1)36 (72)
    18 (15.4)8 (16)0.78
    26 (11.5)5 (10)
    30 (0)1 (2)
Corpus intestinal metaplasia (%)
    047 (92.2)48 (98)
    12 (3.9)1 (2)0.32
    22 (3.9)0 (0)
    30 (0)0 (0)